Founded in 1992, IBSA Farmaceutici Italia, the Italian branch of theIBSA Group, has its headquarters in Lodi, offices in Rome and two production sites, one in Lodi and the other in Cassina de’ Pecchi (MI).
The company has grown rapidly in recent years, now employing more than 500 people and becoming a leading economic, scientific and industrial reality in the Italian pharmaceutical sector. Science, innovation, technology and know-how have always distinguished the IBSA culture and together with investments in research and development, they have allowed the company to build up a unique product portfolio over the years (drugs, medical devices and nutraceuticals) based on the improvement of existing technologies and molecules and able to increase product value for doctors and their patients. IBSA currently operates in 12 main therapeutic areas: Cardiometabolic, Dermatology, Dermoaesthetic, Endocrinology, Reproductive medicine, Osteoarticular, Pain and inflammation, Respiratory, Urology, Ophthalmic, Otolaryngology, Consumer Health.
Research and development activity uses advanced technologies to study new methods for administering drugs, such as pre-filled syringes, softcapsules, orodispersible films, medicated transdermal patches and ointments in BoV (Bag-on-Valve), with the aim of providing healthcare professionals with new, efficient and reliable treatment methods that can contribute to truly improving patients’ quality of life.